Peter Harper

2.1k total citations
62 papers, 1.4k citations indexed

About

Peter Harper is a scholar working on Oncology, Pulmonary and Respiratory Medicine and General Health Professions. According to data from OpenAlex, Peter Harper has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in General Health Professions. Recurrent topics in Peter Harper's work include Lung Cancer Treatments and Mutations (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Primary Care and Health Outcomes (7 papers). Peter Harper is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Ovarian cancer diagnosis and treatment (7 papers) and Primary Care and Health Outcomes (7 papers). Peter Harper collaborates with scholars based in United Kingdom, United States and Belgium. Peter Harper's co-authors include Desmond Yip, Timothy J. Littlewood, Christopher Steer, Christos S. Karapetis, Lionel Fry, Eleni Galani, A. V. Hoffbrand, R. M. H. McMinn, Gavin Marx and P. P. Seah and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer.

In The Last Decade

Peter Harper

61 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Harper 502 407 280 209 185 62 1.4k
E. Franssen 759 1.5× 495 1.2× 287 1.0× 113 0.5× 140 0.8× 35 1.9k
Noel S. Weiss 573 1.1× 316 0.8× 221 0.8× 191 0.9× 107 0.6× 32 1.4k
Jeffrey L. Berenberg 829 1.7× 341 0.8× 180 0.6× 103 0.5× 191 1.0× 63 1.7k
S. M. Crawford 612 1.2× 240 0.6× 409 1.5× 100 0.5× 126 0.7× 56 1.4k
Rejin Kebudi 573 1.1× 470 1.2× 293 1.0× 211 1.0× 239 1.3× 148 1.9k
Jane Bryce 978 1.9× 408 1.0× 175 0.6× 212 1.0× 355 1.9× 41 1.8k
Lynn Ries 927 1.8× 321 0.8× 172 0.6× 189 0.9× 170 0.9× 12 1.9k
P. Babb 615 1.2× 382 0.9× 322 1.1× 382 1.8× 153 0.8× 22 1.4k
Alice Nennecke 1.2k 2.3× 521 1.3× 358 1.3× 310 1.5× 198 1.1× 36 2.0k
D. Dalley 858 1.7× 398 1.0× 213 0.8× 82 0.4× 102 0.6× 35 1.5k

Countries citing papers authored by Peter Harper

Since Specialization
Citations

This map shows the geographic impact of Peter Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Harper more than expected).

Fields of papers citing papers by Peter Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Harper. The network helps show where Peter Harper may publish in the future.

Co-authorship network of co-authors of Peter Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Harper. A scholar is included among the top collaborators of Peter Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Harper. Peter Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Hatem, et al.. (2021). The Impact of COVID-19 Proactive Outreach With Somali Seniors. The Annals of Family Medicine. 19(2). 179–179. 3 indexed citations
2.
Peek, C. J., John M. Westfall, Kurt C. Stange, et al.. (2021). Shared Language for Shared Work in Population Health. The Annals of Family Medicine. 19(5). 450–457. 6 indexed citations
3.
Mendenhall, Tai J., et al.. (2010). The Family Education Diabetes Series (FEDS): community‐based participatory research with a midwestern American Indian community. Nursing Inquiry. 17(4). 359–372. 62 indexed citations
4.
Hirsh, Vera, Peter Harper, Richard J. Cook, Allan Lipton, & Pierre Major. (2007). PD6-3-7: Bone metastases from non-small cell lung cancer (NSCLC) result in meaningful skeletal morbidity within a patient’s lifetime. Journal of Thoracic Oncology. 2(8). S434–S434. 1 indexed citations
5.
Spicer, James, Simon Chowdhury, & Peter Harper. (2006). Targeting novel and established therapies for non-small cell lung cancer. Cancer Letters. 250(1). 9–16. 10 indexed citations
6.
Harper, Peter & Timothy J. Littlewood. (2005). Anaemia of Cancer: Impact on Patient Fatigue and Long-Term Outcome. Oncology. 69(Suppl. 2). 2–7. 65 indexed citations
7.
Marx, Gavin, Glen M. Blake, Eleni Galani, et al.. (2004). Evaluation of the Cockroft–Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients. Annals of Oncology. 15(2). 291–295. 91 indexed citations
8.
Yip, Desmond, Christos S. Karapetis, A. H. Strickland, et al.. (2003). A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies. Annals of Oncology. 14(6). 864–866. 7 indexed citations
9.
Cox, James D., Thierry Le Chevalier, R. Arriagada, et al.. (2003). Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer. 42(2). 15–16. 5 indexed citations
10.
Karapetis, Christos S., A. H. Strickland, Desmond Yip, Christopher Steer, & Peter Harper. (2003). Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single‐centre experience with long‐term follow up*. Internal Medicine Journal. 33(9-10). 427–435. 26 indexed citations
11.
Yip, Desmond, et al.. (2001). COLLECTING DUCT CARCINOMA OF THE KIDNEY ASSOCIATED WITH THE SICKLE CELL TRAIT. International Journal of Clinical Practice. 55(6). 415–417. 3 indexed citations
12.
Steer, Christopher & Peter Harper. (2001). Is there any place for cytotoxic chemotherapy in endometrial cancer?. Best Practice & Research Clinical Obstetrics & Gynaecology. 15(3). 447–467. 2 indexed citations
13.
Yip, Desmond & Peter Harper. (2000). Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer. 28(3). 173–185. 72 indexed citations
14.
Yip, Desmond, et al.. (1999). Matrix Metalloproteinase Inhibitors: Applications in Oncology. Investigational New Drugs. 17(4). 387–399. 74 indexed citations
15.
Ginsberg, Robert J., James D. Cox, H. Bülzebruck, et al.. (1997). Staging classification committee. Lung Cancer. 17. S11–S13. 15 indexed citations
16.
Harper, Peter. (1994). Adolescent measles vaccination. Response rates to mailings addressed to patients vs parents. Archives of Family Medicine. 3(7). 619–622. 9 indexed citations
17.
Madlon-Kay, Diane J., et al.. (1994). Health promotion counseling in residency training. Journal of General Internal Medicine. 9(8). 465–467. 7 indexed citations
18.
Wiltshaw, E., Timothy Perren, I Fryatt, et al.. (1990). Carboplatin and ifosfamide in ovarian cancer phase II and III trials. Cancer Chemotherapy and Pharmacology. 26(S1). S48–S50. 2 indexed citations
19.
Geddes, Duncan M., Elizabeth G. Hill, Kate Law, et al.. (1990). Quality of life during chemotherapy for small cell lung cancer: Assessment and use of a daily diary card in a randomized trial. European Journal of Cancer and Clinical Oncology. 26(4). 484–492. 65 indexed citations
20.
Harper, Peter, R L Souhami, Muriel Houang, et al.. (1981). Computerized axial tomography in the pretreatment assessment of small-cell carcinoma of the bronchus. Cancer. 47(7). 1775–1780. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Franssen Breakdown of academic impact, for papers by Noel S. Weiss Breakdown of academic impact, for papers by Jeffrey L. Berenberg Breakdown of academic impact, for papers by S. M. Crawford Breakdown of academic impact, for papers by Rejin Kebudi Breakdown of academic impact, for papers by Jane Bryce Breakdown of academic impact, for papers by Lynn Ries Breakdown of academic impact, for papers by P. Babb Breakdown of academic impact, for papers by Alice Nennecke Breakdown of academic impact, for papers by D. Dalley
Rankless by CCL
2026